Lower influenza-specific cell-mediated immune responses in individuals with atopic dermatitis compared with healthy controls

In a sub-study of a clinical trial (NCT01737710) investigating the immunogenicity of trivalent inactivated influenza vaccine (IIV3) administered intradermally or intramuscularly to individuals with atopic dermatitis (AD), we assessed T cell and antigen-presenting cell (APC) responses to influenza B...

Full description

Bibliographic Details
Main Authors: Emilie Jalbert, Stephanie Lussier, Michael J. Johnson, Brett Jepson, Agustin Calatroni, Gloria David, Donald Leung, Adriana Weinberg
Format: Article
Language:English
Published: Taylor & Francis Group 2020-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2020.1747374